AANS and CNS Support the Safe Step Act
On April 21, the AANS and the CNS joined the Alliance of Specialty Medicine in supporting the Safe Step Act (H.R. 2163) sponsored by Reps. Raul Ruiz, MD, (D-Calif.), Brad Wenstrup, DPM, (R-Ohio), Lucy McBath (D-Ga.) and Mariannette Miller-Meeks, MD, (R-Iowa). Health insurers often use step therapy — also called “fail first” — to control costs. Step therapy occurs when insurers require patients to fail the first step of treatment — typically a generic or low-cost drug — before moving on to the second step. This legislation would require health plans to establish specific exceptions to medication step-therapy protocols.
Click here to read the Alliance of Specialty Medicine letter.